Oncternal Therapeutics Financials

ONCTDelisted Stock  USD 0.53  0.00  0.00%   
Based on the key indicators related to Oncternal Therapeutics' liquidity, profitability, solvency, and operating efficiency, Oncternal Therapeutics is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.
  
Please note, the imprecision that can be found in Oncternal Therapeutics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Oncternal Therapeutics. Check Oncternal Therapeutics' Beneish M Score to see the likelihood of Oncternal Therapeutics' management manipulating its earnings.

Oncternal Therapeutics Stock Summary

Oncternal Therapeutics competes with CytomX Therapeutics, Assembly Biosciences, Instil Bio, Nuvation Bio, and Protara Therapeutics. Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. Oncternal Therapeutics, Inc. has a research collaboration with Celularity Inc. to evaluate placental derived-cellular therapies targeting ROR1. Oncternal Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 26 people.
Specialization
Healthcare, Biotechnology
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS68236P1075
CUSIP68236P107 40052B108 40052B207 68236P206
LocationCalifornia; U.S.A
Business Address12230 El Camino
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.oncternal.com
Phone858 434 1113
CurrencyUSD - US Dollar

Oncternal Therapeutics Key Financial Ratios

Oncternal Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Oncternal Therapeutics's current stock value. Our valuation model uses many indicators to compare Oncternal Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Oncternal Therapeutics competition to find correlations between indicators driving Oncternal Therapeutics's intrinsic value. More Info.
Oncternal Therapeutics is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Oncternal Therapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Oncternal Therapeutics Market Pulse

 Quote0.53
 Change(%) 0.00  
 Change0.00 
 Open0.53
 Low0.53
 High0.53
 Volume0
 ExchangeNASDAQ

Steps to analyze company Financials for Investing

There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Oncternal Therapeutics is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Oncternal has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.
In summary, you can determine if Oncternal Therapeutics' financials are consistent with your investment objective using the following steps:
  • Review Oncternal Therapeutics' balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
  • Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
  • Study the cash flow inflows and outflows to understand Oncternal Therapeutics' liquidity and solvency.
  • Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
  • Compare Oncternal Therapeutics' financials to those of its peers to see how it stacks up and identify any potential red flags.
  • Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Oncternal Therapeutics' stock is overvalued or undervalued.
Remember, these are just guidelines and should not be the only basis for investment decisions. It is always important to analyze the leading stock market indicators., conduct additional research and seek professional advice if needed.

Oncternal Therapeutics Thematic Clasifications

Oncternal Therapeutics is part of several thematic ideas from Health Management to Management. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic Ideas

Oncternal Therapeutics January 31, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Oncternal Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Oncternal Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Oncternal Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Oncternal Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Oncternal Therapeutics's daily price indicators and compare them against related drivers.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Consideration for investing in Oncternal Stock

If you are still planning to invest in Oncternal Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Oncternal Therapeutics' history and understand the potential risks before investing.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges